Literature DB >> 375959

Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.

N Clausen, T Damsgaard, K Mellemgaard.   

Abstract

1 The antihypertensive effects at rest and during physical exercise of the non-selective beta-adrenoceptor blocker propranolol and the cardioselective beta-adrenoceptor blocker metoprolol were compared in a double-blind cross-over study. 2 Eighteen patients with mild hypertension entered the trial. One patient was withdrawn from the study due to side effects on both drugs. 3 The two beta-adrenoceptor blockers were compared using doses earlier shown to have the same beta-adrenoceptor blocking potency, as measured by their effect on exercise tachycardia in healthy men. 4 Arterial blood pressure was reduced to the same extent by propranolol and metoprolol at rest as well as during submaximal work. 5 It is concluded that the antihypertensive effect of beta-adrenoceptor blockers is mainly mediated through blockade of the beta 1-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375959      PMCID: PMC1429639          DOI: 10.1111/j.1365-2125.1979.tb00949.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind cross-over study.

Authors:  C Bengtsson
Journal:  Acta Med Scand       Date:  1976

2.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.

Authors:  R C Tarazi; H P Dustan
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

3.  Metoprolol in the long-term treatment of hypertension.

Authors:  M B Comerford; A Pringle
Journal:  Practitioner       Date:  1976-12

4.  Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.

Authors:  L Hansson; H Aberg; S Jameson; B Karlberg; R Malmcrona
Journal:  Acta Med Scand       Date:  1973-12

5.  Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.

Authors:  L Hansson; N C Henningsen; B Karlberg; H Aberg; S Jameson; R Malmcrona; C Hersvall
Journal:  Int J Clin Pharmacol       Date:  1974-10

6.  Controlled study of atenolol in treatment of hypertension.

Authors:  L Hansson; H Aberg; B E Karlberg; A Westerlund
Journal:  Br Med J       Date:  1975-05-17

7.  A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol.

Authors:  L Hansson; A Westerlund; H Aberg; B E Karlberg
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

  7 in total
  1 in total

1.  Blood pressure and catecholamines following exercise during selective beta-blockade in hypertension.

Authors:  R Vandongen; B Margetts; L J Beilin; N deKlerk; P Rogers
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.